Murae Organisor announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 24 April 2024 .Powered by Capital Market - Live News

Net profit of Earum Pharmaceuticals declined 97.08% to Rs 0.04 crore in the quarter ended December 2023 as against Rs 1.37 crore during the previous quarter ended December 2022. Sales declined 65.81% to Rs 0.40 crore in the quarter ended December 2023 as against Rs 1.17 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales0.401.17 -66 OPM %15.0011.97 - PBDT0.061.40 -96 PBT0.041.37 -97 NP0.041.37 -97 Powered by Capital Market - Live News

Earum Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 February 2024. The meeting would commence at 4.00 pm.Powered by Capital Market - Live News

Earum Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 January 2024.Powered by Capital Market - Live News

Net loss of Earum Pharmaceuticals reported to Rs 0.87 crore in the quarter ended September 2023 as against net profit of Rs 0.04 crore during the previous quarter ended September 2022. Sales declined 93.95% to Rs 0.43 crore in the quarter ended September 2023 as against Rs 7.11 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales0.437.11 -94 OPM %-220.930.84 - PBDT-0.960.06 PL PBT-0.980.04 PL NP-0.870.04 PL Powered by Capital Market - Live News